Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 3,025.00
+5.00 (0.17%)
Feb 17, 2026, 9:22 AM GMT
Genus Market Cap
Genus has a market cap or net worth of 2.02 billion as of February 17, 2026. Its market cap has increased by 62.34% in one year.
Market Cap
2.02B
Enterprise Value
2.24B
Revenue
672.80M
Ranking
n/a
PE Ratio
104.67
Stock Price
3,025.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 2.02B, an increase of 6,423.06%. That is a compound annual growth rate of 16.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.03B | 16.76% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.31B |
| Oxford Biomedica | 994.46M |
| PureTech Health | 311.29M |
| Avacta Group | 253.69M |
| Scancell Holdings | 145.29M |
| Bioventix | 90.13M |
| 4basebio | 87.45M |
| Faron Pharmaceuticals Oy | 63.10M |